Peter Thompson

OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals for medical devices and diagnostics.

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

Raised $250,000,000.00 from Cormorant Capital, EcoR1 Capital, Novo Holdings, Third Rock Ventures and OrbiMed.

Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.

Raised $221,000,000.00 from EcoR1 Capital, Frazier Healthcare Partners, OrbiMed, RA Capital Management, Nextech Invest, Pontifax, Boxer Capital, U.S. Venture Partners, Nantahala Capital Management and Fidelity.

Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.

Raised $337,799,978.00 from Mission BioCapital.

Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer.

Raised $55,600,000.00 from Prospect Venture Partners, Oxford Bioscience Partners, Venrock, Frazier Healthcare Partners, ARCH Venture Partners and Relay Ventures.